Inactive Instrument

Insiders Merck & Co., Inc. Euronext Paris

Equities

Robert Davis, Merck CEO: Another obesity drug?	03-28	MT
Global markets live: Darktrace, Merck, Meta, Apple, Eli Lilly...	03-07
Merck & Co. Insider Sold Shares Worth $29,538,998, According to a Recent SEC Filing	02-15	MT
Merck & Co. Insider Sold Shares Worth $4,805,521, According to a Recent SEC Filing	02-15	MT
Merck & Co. Insider Sold Shares Worth $1,845,083, According to a Recent SEC Filing	02-12	MT
Merck & Co. Insider Sold Shares Worth $2,411,111, According to a Recent SEC Filing	02-05	MT
Merck & Co. Insider Sold Shares Worth $6,420,349, According to a Recent SEC Filing	02-02	MT
Stéphane Bancel, CEO of Moderna: Merck-Moderna vaccine reduces risk of skin cancer recurrence	12-14	MT
Good Energy says ZapMap expands into mainland Europe	12-13	AN
Doubleverify Holdings Insider Sold Shares Worth $56,765,625, According to a Recent SEC Filing	11-29	MT
Merck & Co., Inc. Announces Management Changes, Effective on December 4, 2023	11-28	CI
Merck & Co. Insider Sold Shares Worth $213,061, According to a Recent SEC Filing	11-13	MT
Merck & Co. Insider Sold Shares Worth $4,602,668, According to a Recent SEC Filing	11-09	MT
Insider Sell: Merck & Co.	15/08/23	MT
Insider Sell: Merck & Co.	04/08/23	MT
Top Stories at Midday: Yellow Calls it Quits; JNJ Unit Loses Second Bid at Bankruptcy; JB Hunt Buys Nikola Trucks, Walmart Raises Flipkart Stake	31/07/23	MT
Insider Sell: Merck & Co.	05/05/23	MT
Insider Sell: Merck & Co.	05/05/23	MT
Insider Sell: Merck & Co.	02/05/23	MT
Insider Sell: Merck & Co.	16/02/23	MT

No results for this search

Merck & Co.'s Keytruda Combo Improves Pathological Complete Response Rate in Late-stage Breast Cancer Study

July 28, 2023 at 02:02 pm